Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. NAFTILUX (naftidrofuryl (hydrogénooxalate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

NAFTILUX (naftidrofuryl (hydrogénooxalate de))

Medicine - Posted on May 17 2019 - Updated on Jun 12 2019
Active substance (DCI)
  • naftidrofuryl (hydrogénooxalate de)
history (4)
  • 1/23/19

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))

    Intérêt clinique insuffisant pour justifier son remboursement dans le traitement symptomatique de la claudication intermitte...
    icône flèche
  • 1/18/12

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))
    icône flèche
  • 12/5/07

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))
    icône flèche
  • 5/31/06

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))

    NAFTILUX (naftidrofuryl (hydrogénooxalate de))
    icône flèche
Technical information
ATC code
  • C04AX21
Manufacturer
THERABEL LUCIEN PHARMA
Presentation

NAFTILUX 100 mg, gélule
Boîte de 20 gélules - Code CIP : 326 642-5

NAFTILUX 200 mg, gélule (code CIS : 61621776)
plaquette(s) thermoformée(s) PVC-aluminium de 20 gélule(s) - Code CIP : 34009 325 765 6 2

All our publications
    Alzheimer’s disease and mental disorders Drug therapy Embolism, thrombosis and stenosis Geriatrics Peripheral vascular diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
vA4R2ag2MhSS76D7